Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon

Regulatory Peptides

Volumn 130, Issue 1-2, 2005, Pages 42-47

  Amato, Antonella ^a   Corti, Angelo ^b   Serio, Rosa ^a   Mulè, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

CGA derived peptides; Chromogranin A; Intestinal smooth muscle; Nitric oxide; Vasostatin 1

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; APAMIN; CHROMOGRANIN A; CHROMOGRANIN A [7-57]; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5 A 8; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEPTIDE DERIVATIVE; RECOMBINANT CHROMOGRANIN A [1-78]; RECOMBINANT HORMONE; TETRODOTOXIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; ASCENDING COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HORMONE INHIBITION; INTESTINE CONTRACTION; INTESTINE MUSCLE; INTESTINE PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE TONE;

ANIMALS; APAMIN; CALRETICULIN; CHROMOGRANIN A; CHROMOGRANINS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GASTROINTESTINAL TRACT; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXADIAZOLES; PEPTIDE FRAGMENTS; PEPTIDES; PRESSURE; PROTEIN STRUCTURE, TERTIARY; QUINOXALINES; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TETRODOTOXIN; TIME FACTORS;

EID: 22044446261     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.03.004     Document Type: Article

References (33)

1. H. Winkler, and R. Fischer-Colbrie The chromogranin A and B: the first 25 years and future perspective Neuroscience 49 1992 497 528
2. H. Lagercrantz On the composition and function of large dense core of vescicles in sympathetic nerves Neuroscience 1 1976 81 92
3. D.V. Cohn, R. Zangerle, R. Fischer-Colbrie, L.L. Chu, J.J. Elting, and J.W. Hamilton Similarity of secretory protein-I from parathyroid gland to chromogranin A, from adrenal medulla Proc Natl Acad Sci U S A 79 1982 6056 6059
4. M. Ehrhart, D. Grube, M.F. Bader, D. Aunis, and M. Gratzl Chromogranin A in the pancreatic islet: cellular and subcellular distribution J Histochem Cytochem 34 1986 1673 1682
5. D.T. O'Connor, R.J. Parmer, and L.J. Deftos Chromogranin A: studies in the endocrine system Trans Assoc Am Physicians 97 1984 242 250
6. D.T. O'Connor Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum Regul Pept 6 1983 263 280
7. R. Fischer-Colbrie, H. Lassmann, C. Hagn, and H. Winkler Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues Neuroscience 16 1985 547 555
8. J. Qian, W.F. Hickey, and R.H. Angeletti Neuroendocrine cells in intestinal lamina propria: detection with antibodies to chromogranin A J Neuroimmunol 17 1988 159 165
9. L. Taupenot, K.L. Harper, and D.T. O'Connor The chromogranin- secretogranin family N Engl J Med 348 2003 1134 1149
10. A. Corti, and E. Ferrero Chromogranin A: more than a marker for tumor diagnosis and prognosis Curr Med Chem-Imm Endoc Metab Agents 4 2004 161 167
11. A. Corti, R. Ferrari, and C. Ceconi Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure Adv Exp Med Biol 482 2000 351 359
12. M. El-Salhy, A. Danielsson, R. Stenling, and L. Grimelius Colonic endocrine cells in inflammatory bowel disease J Intern Med 242 1997 413 419
13. K.B. Helle, M.H. Metz-Boutigue, and D. Aunis Chromogranin A as a calcium-binding precursor for a multitude of regulatory peptides for the immune, endocrine and metabolic systems Curr Med Chem 1 2001 119 140
14. S. Aardal, and K.B. Helle The vasoinhibitory activity of bovine chromogranin A (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels Regul Pept 41 1992 9 18
15. S. Aardal, K.B. Helle, S. Elsayed, R.K. Reed, and G. Serck-Hanssen Vasostatin, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments J Neuroendocrinol 5 1993 405 412
16. R.H. Angeletti, S. Aardal, G. Serck-Hanssen, P. Gee, and K.B. Helle Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A Acta Physiol Scand 152 1994 11 19
17. J.F. Brekke, J. Kirkeleit, K. Lugardon, and K.B. Helle Vasostatins. Dilators of bovine resistance arteries Adv Exp Med Biol 482 2000 239 246
18. J.F. Brekke, G.J. Osol, and K.B. Helle N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries Regul Pept 105 2002 93 100
19. B. Tota, R. Mazza, T. Angelone, G. Nullans, M.H. Metz-Boutigue, and D. Aunis Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart Regul Pept 114 2003 123 130
20. A. Corti, C. Mannarino, R. Mazza, T. Angelone, R. Longhi, and B. Tota Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart Gen Comp Endocrinol 136 2004 217 224
21. S. Imbrogno, T. Angelone, A. Corti, C. Adamo, K.B. Helle, and B. Tota Influence of vasostatins, the chomogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action Gen Comp Endocrinol 139 2004 20 28
22. G.M. Portela-Gomes Chromogranin A immunoreactivity in neuroendocrine cells in the human gastrointestinal tract and pancreas Adv Exp Med Biol 482 2000 193 203
23. J.E. Ghia, F. Crenner, S. Rohr, C. Meyer, M.H. Metz-Boutigue, and D. Aunis A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study Regul Pept 121 2004 31 39
24. F. Mulè, M.C. Baffi, and M.C. Cerra Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon Br J Pharmacol 136 2002 367 374
25. S. Ratti, F. Curnis, R. Longhi, B. Colombo, A. Gasparri, and F. Magni Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells J Biol Chem 275 2000 29257 29263
26. A. Corti, L.P. Sanchez, A. Gasparri, F. Curnis, R. Longhi, and A. Brandazza Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins)-evidence of dimer-monomer equilibria Eur J Biochem 248 1997 692 699
27. A. Gasparri, A. Sidoli, L.P. Sanchez, R. Longhi, A.G. Siccardi, and P.C. Marchisio Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain J Biol Chem 272 1997 20835 20843
28. + channels Br J Pharmacol 127 1999 514 520
29. Z. Shen, L.T. Larsson, G. Malmfors, K. Oberg, B. Eriksson, and F. Sundler Chromogranin A and B in neuronal elements in Hirschsprung's disease: an immunocytochemical and radioimmunoassay study J Pediatr Surg 29 1994 1293 1301
30. M.M. Byrne, G.P. McGregor, T. Barth, M. Rothmund, B. Goke, and R. Arnold Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma Digestion 63 2001 61 68
31. B. Colombo, R. Longhi, C. Marinzi, F. Magni, A. Cattaneo, and S.H. Yoo Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion J Biol Chem 277 2002 45911 45919
32. N. Suthamnatpong, F. Hata, A. Kanada, T. Takeuchi, and O. Yagasaki Mediators of nonadrenergic, noncholinergic inhibition in the proximal, middle and distal regions of rat colon Br J Pharmacol 108 1993 348 355
33. R. Serio, F. Mulè, and A. Postorino Nonadrenergic, noncholinergic inhibitory junction potentials in rat proximal colon: role of nitric oxide Can J Physiol Pharm 73 1995 79 84